P318: Protein FingerPrint assays reflecting neutrophil activity, mucosal damage, and tissue fibrosis are surrogate biomarkers for mucosal healing in pediatric Crohn's diseaseECCO’23 CopenhagenYear: 2023
Authors: Mortensen, J.(1)*;Focht, G.(2);Pehrsson, M.(1);Griffiths, A.M.(3);Alexdóttir, M.S.(1);Quteineh, A.(2);Church, P.C.(3);Baldassano, R.N.(4);Silverstein, J.(5);Karsdal, M.A.(1);Turner, D.(2);
(1)Nordic Bioscience A/S, Biomarkers & Research, Herlev, Denmark;(2)Shaare Zedek Medical Center, Pediatric Gastroenterology and Nutrition Institute, Jerusalem, Israel;(3)Hospital for Sick Children, Division of Gastroenterology, Toronto, Canada;(4)The Children's Hospital of Philadelphia, Division of Gastroenterology- Hepatology- and Nutrition, Philadelphia, United States;(5)Harvard Medical School, Division of Gastroenterology- Hepatology and Nutrition Instructor of Pediatrics, Boston, United States;
P319: Characteristics of filgotinib-treated patients with Ulcerative Colitis who achieve sustained corticosteroid-free remission: Post hoc analysis of the phase 2b/3 SELECTION studyECCO’23 CopenhagenYear: 2023
Authors: Kobayashi, T.(1)*;Dignass, A.(2);Roblin, X.(3);Fujitani, Y.(4);Oortwijn, A.(5);Jamoul, C.(6);Hibi, T.(1);
(1)Kitasato University Kitasato Institute Hospital, Center for Advanced IBD Research and Treatment, Tokyo, Japan;(2)Goethe University, Department of Medicine I- Agaplesion Markus Hospital, Frankfurt am Main, Germany;(3)University Hospital of Saint-Étienne, IBD Unit, Saint-Étienne, France;(4)Gilead Sciences, K.k., Tokyo, Japan;(5)Galapagos, Nv, Leiden, The Netherlands;(6)Galapagos, Nv, Mechelen, Belgium;
P320: Confocal Laser Endomicroscopy to predict the efficacy of vedolizumab as first-line biotherapy in ulcerative colitisECCO’23 CopenhagenYear: 2023
Authors: Quénéhervé, L.(1);Trang-Poisson, C.(2);Fantou, A.(3);Flamant, M.(4);Durand, T.(5);Bouguen, G.(6);Bregeon, J.(7);Oullier, T.(7);Amil, M.(8);Dewitte, M.(6);Bardot, S.(9);Braudeau, C.(10);Josien, R.(3);Neunlist, M.(7);Bourreille, A.(11)*;
(1)CHU Brest, Gastroenterology, Brest, France;(2)CHU Nantes, Gastroenterology, Nantes, France;(3)CHU Nantes, Immunology, Nantes, France;(4)Clinique Jules Verne, Gastroenterology, Nantes, France;(5)Nantes Université, TENS- Inserm 1235, Nantes, France;(6)CHU Rennes, Gastroenterology, Rennes, France;(7)Nantes Université, TENS Inserm 1235, Nantes, France;(8)CH Vendée, Gastroenterology, La Roche Sur Yon, France;(9)CHU Nantes, CIC Inserm 1314, Nantes, France;(10)CHU Nantes, Immunolgy, Nantes, France;(11)CHU Hotel Dieu, Gastroenterology, Nantes Cedex 1, France;
P322: Mycobiome signature in pediatric patients with Inflammatory Bowel DiseaseECCO’23 CopenhagenYear: 2023
Authors: Murugesan, S.(1);Kumar, M.(1);Saadaoui, M.(1); Elhag, D.A.(1); Hendaus, M.A.(2); Ibrahim, N.(3); Al-Mudhaka, F.(3); AbuHazima, K.(3); Akobeng, A.(3);Elawad, M.(3);Al Khodor, S.(1)*;
(1)Sidra Medicine, Research, Doha, Qatar;(2)Sidra Medicine, Pediatrics, Doha, Qatar;(3)Sidra Medicine, Pediatrics Gastroenterology- Hepatology and Nutrition, Doha, Qatar;
P323: The Rate of and Risk of Dysplasia in Long Standing Ulcerative Colitis Patients Among Middle-Eastern PopulationECCO’23 CopenhagenYear: 2023
Authors: Altuwaijiri, M.(1); Alharbi, O.(1); Alruthia, Y.(2); Aljebreen, A.(1); Almadi , M.(1); Almalki , Y.(1); Alrashed, A.W.(1); Alzahran, S.A.(1); Almuhaya, H.(1); Alhowaish, N.(1); Alshehri, K.F.(1); Alrushud , S.S.(1);Alanazi, W.S.(1);Azzam, N.(1)*;
(1)King Saud University, Department of Medicine- Division of Gastroenterology, Riyadh, Saudi Arabia;(2)King Saud University, Department of Clinical Pharmacy- College of Pharmacy, Riyadh, Saudi Arabia;
P324: Long-term impact of the COVID-19 pandemic on Inflammatory Bowel Disease healthcare utilization: A two-year nationwide updateECCO’23 CopenhagenYear: 2023
Authors: DerksEduarda Wilhelmina, M.(1)*;van Lierop, L.(2);te Groen, M.(1);Kuijpers, C.(3);Nagtegaal, I.D.(4);Hoentjen, F.(2);
(1)Radboud University Medical Centre, Department of Gastroenterology and Hepatology, Nijmegen, The Netherlands;(2)University of Alberta, Department of Medicine- Division of Gastroenterology, Edmonton, Canada;(3)PALGA Foundation, Pathology, Houten, The Netherlands;(4)Radboud Univserity Medical Centre, Department of Pathology, Nijmegen, The Netherlands;
P325: Proton pump inhibitors are associated with a disabling course of Crohn's diseaseECCO’23 CopenhagenYear: 2023
Authors: Barrau, M.(1)*;Duru, G.(2);Nancey, S.(3);Phelip, J.M.(4);Cheifetz, A.(5);Papamichael, K.(5);Paul, S.(6);Xavier, R.(1);
(1)Saint Etienne University Hospital, Department of gastroenterology, Saint Etienne, France;(2)Claude Bernard University, Université Claude Bernard, Lyon, France;(3)Lyon-Sud University Hospital, Department of Gastroenterology, Lyon, France;(4)Saint Etienne University Hospital, Department of gastro enterology, Saint Etienne, France;(5)Beth Israel Deaconess Medical Center, Center for Inflammatory Bowel Disease, Boston, United States;(6)Centre International de Recherche en Infectiologie- Team GIMAP, Department of Immunology, Saint Etienne, France;
P326: PREFAB-study: PRediction tool for Early identification of patients at risk of Crohn's disease in perianal Fistulas and ABscesses: interim analysis of a prospective pilot study at a non-academic, IBD-expert centre in the NetherlandsECCO’23 CopenhagenYear: 2023
Authors: Munster, L.(1)*;de Groof, E.J.(1);van Dieren, S.(2);Mundt, M.W.(3);D'Haens, G.R.A.M.(4);Bemelman, W.A.(5);Buskens, C.J.(5);van der Bilt, J.D.W.(1);
(1)Flevoziekenhuis/Amsterdam UMC- location AMC, Department of Surgery, Almere/Amsterdam, The Netherlands;(2)Amsterdam UMC- location AMC, Department of Clinical Epidemiology, Amsterdam, The Netherlands;(3)Flevoziekenhuis, Department of Gastroenterology, Almere, The Netherlands;(4)Amsterdam UMC- location AMC, Department of Gastroenterology, Amsterdam, The Netherlands;(5)Amsterdam UMC- location AMC, Department of Surgery, Amsterdam, The Netherlands;
P327: Characteristics of esophago-gastro-duodenal Crohn's disease in the biologic era: a nationwide study of the Young GETECCU GroupECCO’23 CopenhagenYear: 2023
Authors: López García, A.(1)*;Benítez, J.M.(2);Maroto-Martín, C.(3);Fernández-Prada, S.J.(3);Marquina, V.(4);Rodríguez, G.E.(5);Mesonero, F.(6);Lucendo, A.J.(7);Flórez-Díez, P.(8);Casanova, M.J.(9);García-Morales, N.(10);Miranda, J.(11);Vicuña, M.(12);Font, G.(1);Suárez-Ferrer, C.(13);Bernal, L.(14);Peries, L.(15);Mínguez, A.(16);Tejedor, J.(17);Pérez-Galindo, P.(18);Elosua, A.(19);Lastiri, E.A.(20);Brunet, E.(21);Llaó, J.(22);Rodríguez-Lago, I.(23);Ferreiro-Iglesias, R.(24);López, L.(25);González, I.(26);Ortega, S.P.(27);Monsalve, S.(28);Márquez-Mosquera, L.(1);González-Vivó, M.(1);Murciano, F.(1);Zabana, Y.(4);Barreiro-de Acosta, M.(24);
(1)Hospital del Mar Barcelona and Institut Mar d'Investigacions Mèdiques IMIM Barcelona, Gastroenterology, Barcelona, Spain;(2)Hospital Universitario Reina Sofía Córdoba, Gastroenterology, Córdoba, Spain;(3)Hosptal Universitario Río Hortega Valladolid, Gastroenterology, Valladolid, Spain;(4)Hospital Universitari Mútua Terrassa and Centro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas CIBERehd, Gastroenterology, Terrassa, Spain;(5)Hospital Universitario Nuestra Señora de la Candelaria Tenerife, Gastroenterology, Tenerife, Spain;(6)Hospital Universitario Ramón y Cajal Madrid, Gastroenterology, Madrid, Spain;(7)Hospital General de Tomelloso and Centro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas CIBERehd, Gastroenterology, Tomelloso, Spain;(8)Hospital Universitario Central de Asturias Oviedo, Gastroenterology, Oviedo, Spain;(9)Hospital Universitario de La Princesa- Instituto de Investigación Sanitaria Princesa- Madrid and Centro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas CIBERehd, Gastroenterology, Madrid, Spain;(10)Hospital Álvaro Cunqueiro Vigo, Gastroenterology, Vigo, Spain;(11)Hospital Gregorio Marañón Madrid, Gastroenterology, Madrid, Spain;(12)Hospital Universitario Navarra, Gastroenterology, Pamplona, Spain;(13)Hospital Universitario La Paz Madrid, Gastroenterology, Madrid, Spain;(14)Hospital Universitario Alicante, Gastroenterology, Alicante, Spain;(15)Hospital Universitari Josep Trueta Girona, Gastroenterology, Girona, Spain;(16)Hospital Universitario La Fe Valencia, Gastroenterology, Valencia, Spain;(17)Hospital Universitario Cabueñes, Gastroenterology, Gijón, Spain;(18)Complexo Hospitalario Universitario de Pontevedra, Gastroenterology, Pontevedra, Spain;(19)Hospital García Orcoyen Estella, Gastroenterology, Estella, Spain;(20)Hospital Universitari Vall d'Hebrón Barcelona, Gastroenterology, Barcelona, Spain;(21)Hospital Universitari Parc Taulí Sabadell and Centro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas CIBERehd, Gastroenterology, Sabadell, Spain;(22)Althaia- Xarxa Assistencial Universitària de Manresa, Gastroenterology, Manresa, Spain;(23)Hospital Universitario de Galdakao, Gastroenterology, Galdakao, Spain;(24)Hospital Clínico Universitario de Santiago, Gastroenterology, Santiago, Spain;(25)Hospital Sant Joan de Reus, Gastroenterology, Reus, Spain;(26)Hospital Universitario Puerta de Hierro Madrid, Gastroenterology, Madrid, Spain;(27)Hospital de Inca, Gastroenterology, Inca, Spain;(28)Hospital Infanta Elena Valdemoro, Gastroenterology, Madrid, Spain;on behalf of Young Group of GETECCU
P328: Holistic well-being as Patient-reported outcomes (PROs) in translational IBD research: Prospective capture of CUCQ32 as study endpoints for mechanistic biomarker MUSIC/GIDAMPs study.ECCO’23 CopenhagenYear: 2023
Authors: Hall, R.(1)*;Chuah, C.S.(1);Brownson, E.(2);Poulose, B.(1);Athena, O.(1);Mowat, C.(3);Macdonald, J.(2);Seenan, J.P.(2);Ho, G.T.(1);
(1)University of Edinburgh, Centre for Inflammation Research- Western General Hospital, Edinburgh, United Kingdom;(2)University of Glasgow, Gastroenterology Department- Queen Elizabeth Hospital, Glasgow, United Kingdom;(3)University of Dundee, Gastroenterology Department- Ninewells Hospital, Dundee, United Kingdom;
P329: Stool multiplex molecular PCR assay in comparison to conventional stool tests for detecting gastrointestinal infections as cause of flares in Inflammatory Bowel DiseaseECCO’23 CopenhagenYear: 2023
Authors: Kutar, M.(1)*;Desai, D.(2);Abraham, P.(2);Gupta, T.(2);
(1)P.D. Hinduja Hospital and Medical Research Centre, Gastroenterology, Mumbai, India;(2)P.D Hinduja Hospital and Medical Research Centre, Gastroenterology, Mumbai, India;
P330: Ultrasound remission after biologic induction predicts long-term endoscopic remission in Crohn's diseaseECCO’23 CopenhagenYear: 2023
Authors: Allocca, M.(1)*;Dell'Avalle , C.(2);Furfaro, F.(3);Zilli, A.(3);Radice, S.(3);D'Amico, F.(3);Peyrin-Biroulet, L.(4);Fiorino, G.(3);Danese, S.(3);
(1)IRCCS San Raffaele Hospital, Gastroenterology and Endoscopy, Milan, Italy;(2)Humanitas University, Biomedical Sciences, Milan, Central African Republic;(3)IRCCS San Raffaele Hospital, Gastroenterology and Endoscopy, Milan, Italy;(4)Nancy University hospital, Inserm- NGERE, Nancy, France;
P331: Risk Factors and Prediction Model for Fecal Incontinence in Patients with Crohn's Disease: A Multicenter StudyECCO’23 CopenhagenYear: 2023
Authors: Wang, C.(1)*;Yang, F.(2);Qiao, L.(1);Chen, Q.(1);Chen, H.(1);Li, Y.(3);Zhang, X.(4);Liao, X.(5);Cao, L.(3,6);Xu, H.(1);Xiang, Y.(1);Wang, X.(7);Yang, B.(1);
(1)Affiliated Hospital of Nanjing University of Chinese Medicine- Jiangsu Province Hospital of Chinese Medicine, Department of Colorectal Surgery, Nanjing, China;(2)University of New South Wales, Faculty of Science, Sydney, Australia;(3)Jinling Hospital- Medical School of Nanjing University, Department of General Surgery, Nanjing, China;(4)Nanjing Drum Tower Hospital- The Affiliated Hospital of Nanjing University Medical School, Department of Gastroenterology, Nanjing, China;(5)Key Laboratory of Cancer Prevention- Ministry of Education- The Second Affiliated Hospital, Department of Colorectal Surgery and Oncology, Zhejiang, China;(6)The Second Hospital of Nanjing- Nanjing Hospital Affiliated to Nanjing University of Traditional Chinese Medicine, Department of Gastroenterology, Nanjing, China;(7)Affiliated Hospital of Nanjing University of Chinese Medicine- Jiangsu Province Hospital of Chinese Medicine, Department of GCP Research Center, Nanjing, China;Department of Colorectal Surgery Affiliated Hospital of Nanjing University of Chinese Medicine Jiangsu Province Hospital of Chinese Medicine Nanjing China
P333: Early intestinal ultrasound remission is associated with endoscopic healing after one year of infliximab therapy in Crohn's disease: a multicentre prospective studyECCO’23 CopenhagenYear: 2023
Authors: Revés, J.(1)*;Morão, B.(1);Nascimento, C.(1);Frias-Gomes, C.(1);Cúrdia Gonçalves, T.(2);Freitas, M.(2);Castro, F.(2);Moreira, M.J.(2);Cotter, J.(2);Pereira, F.(3);Caldeira, A.(3);Sousa, R.(3);Coelho, R.(4);Macedo, G.(4);Glória, L.(1);Torres, J.(1);Palmela, C.(1);
(1)Hospital Beatriz Ângelo, Gastroenterology, Loures, Portugal;(2)Hospital da Senhora da Oliveira- Life and Health Sciences Research Institute- School of Medicine- University of Minho- Braga- ICVS/3B's- PT Government Associate Laboratory, Gastroenterology, Guimarães/Braga, Portugal;(3)Unidade Local de Saúde de Castelo Branco- EPE- Hospital Amato Lusitano, Gastroenterology, Castelo Branco, Portugal;(4)Centro Hospitalar de São João, Gastroenterology, Porto, Portugal;
P334: Respiratory Manifestations and Association Between Disease Activity in Patients with Inflammatory Bowel Disease in a Reference Center in Salvador, Bahia, Brazil.ECCO’23 CopenhagenYear: 2023
Authors: Fortes, F.(1,2)*;Gonçalves, J.(3);Nery, E.(4);Arenas, L.(4);Mota, J.(1);Pimentel, A.(1);Almeida, N.(5);Santos, A.M.(3);Surlo, V.(5);Santana, G.(4);
(1)Roberto Santos General Hospital, Departament of Gastroenterology, Salvador, Brazil;(2)Federal University of Bahia, Posgraduate program in medicine and health, Salvador, Brazil;(3)Bahia School of Medicine and Public Health, Medicine, Salvador, Brazil;(4)Bahia State University, Medicine, Salvador, Brazil;(5)Roberto Santos General Hospital, Department of Gastroenterology, Salvador, Brazil;
P335: Impact of cancer therapy on the course of Inflammatory Bowel Disease (ONCOEII study of GETECCU)ECCO’23 CopenhagenYear: 2023
Authors: Pérez Galindo, P.(1)*;Benítez, J.M.(2);Rubín de Célix, C.(3);Mesonero, F.(4);Castaño García, A.(5);García, M.J.(6);Vicuña, M.(7);Bernal, L.(8);Bertoletti, F.(9);Ramírez Castro, C.(10);Sánchez-Azofra, M.(11);Sánchez-Delgado, L.(12);Ponferrada, Á.(13);Tejido Sandoval, C.(14);Capilla, M.(15);Laredo de la Torre, V.(16);Diz-Lois, M.T.(17);Dueñas Sadornil, C.(18);García-Morales, N.(19);González-Vivo, M.(20);López-Cauce, B.(21);Melcarne, L.(22);Calviño-Suárez, C.(23);Lastiri González, E.(24);Ramírez de la Piscina, P.(25);Pérez-Gisbert, J.(3);Pérez Martínez, I.(5);Castro, B.(6);Cousillas, A.(26);Mañosa, M.(27);Carpio, D.(1);Barreiro-de Acosta, M.(23);
(1)Complexo Hospitalario Universitario de Pontevedra, Gastroenterology Department, Pontevedra, Spain;(2)Hospital Universitario Reina Sofía. Instituto Maimónides de Investigación Biomédica de Córdoba IMIBIC, Gastroenterology Department, Córdoba, Spain;(3)Hospital Universitario La Princesa. Instituto de Investigación Sanitaria La Princesa IIS La Princesa. Universidad Autónoma de Madrid. Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas CIBERehd, Gastroenterology Department, Madrid, Spain;(4)Hospital Universitario Ramón y Cajal. Universidad de Alcalá. Instituto Ramón y Cajal de Investigación Sanitaria IRYCIS, Gastroenterology Department, Madrid, Spain;(5)Hospital Universitario Central de Asturias, Gastroenterology Department, Oviedo, Spain;(6)Hospital Universitario Marqués de Valdecilla. Instituto de Investigación Marqués de Valdecilla IDIVAL, Gastroenterology Department, Santander, Spain;(7)Hospital Universitario de Navarra, Gastroenterology Department, Pamplona, Spain;(8)Hospital General Universitario de Alicante Doctor Balmis. Instituto de Investigación Sanitaria y Biomédica de Alicante ISABIAL, Gastroenterology Department, Alicante, Spain;(9)Hospital de la Santa Creu i Sant Pau, Gastroenterology Department, Barcelona, Spain;(10)Hospital Universitario de Galdakao-Usansolo, Gastroenterology Department, Galdakao, Spain;(11)Hospital Universitario La Paz. Instituto de Investigación Hospital Universitario La Paz IdiPaz, Gastroenterology Department, Madrid, Spain;(12)Hospital Universitario Río Ortega, Gastroenterology Department, Valladolid, Spain;(13)Hospital Universitario Infanta Leonor, Gastroenterology Department, Madrid, Spain;(14)Complexo Hospitalario Universitario de Ourense, Gastroenterology Department, Ourense, Spain;(15)Hospital Clínico Universitario de Valencia, Gastroenterology Department, Valencia, Spain;(16)Hospital Clínico Universitario Lozano Blesa, Gastroenterology Department, Zaragoza, Spain;(17)Complexo Hospitalario Universitario de A Coruña, Gastroenterology Department, A Coruña, Spain;(18)Hospital Universitario de Cáceres, Gastroenterology Department, Cáceres, Spain;(19)Hospital Universitario Álvaro Cunqueiro. Instituto de Investigación Sanitaria Galicia Sur IIS Galicia Sur, Gastroenterology Department, Vigo, Spain;(20)Hospital del Mar, Gastroenterology Department, Barcelona, Spain;(21)Hospital General Universitario Gregorio Marañón. Instituto de Investigación Sanitaria Gregorio Marañón IiSGM, Gastroenterology Department, Madrid, Spain;(22)Hospital Universitari Parc Taulí, Gastroenterology Department, Sabadell, Spain;(23)Complexo Hospitalario Universitario de Santiago de Compostela, Gastroenterology Department, Santiago de Compostela, Spain;(24)Hospital Universitari Vall d'Hebron, Gastroenterology Department, Barcelona, Spain;(25)Hospital Universitario de Araba-Txagorritxu, Gastroenterology Department, Vitoria, Spain;(26)Complexo Hospitalario Universitario de Pontevedra, Oncology Department, Pontevedra, Spain;(27)Hospital Universitari Germans Trias i Pujol- Badalona. Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas CIBERehd, Gastroenterology Department, Badalona, Spain;GETECCU
P336: Endoscopic scores as predictors of treatment failure in Ulcerative ColitisECCO’23 CopenhagenYear: 2023
Authors: Ferreira, A.I.(1)*;Lima Capela, T.(1);Xavier, S.(1);Arieira, C.(1);Cúrdia Gonçalves, T.(1);Dias de Castro, F.(1);Moreira, M.J.(1);Cotter, J.(1);
(1)Hospital da Senhora da Oliveira - Guimarães, Gastroenterology Department, Guimarães, Portugal;
P337: Developing Preliminary MRI-based Classifier for Perianal Fistulizing Crohn's Disease by Using Deep Convolutional Neural NetworksECCO’23 CopenhagenYear: 2023
Authors: Zhang, H.(1)*;Li, L.(2);Deng, K.(2);Li , W.(3);Ren, D.(1);
(1)The Sixth Affiliated Hospital of Sun Yat-sen University, Department of Colorectal Surgery, Guangzhou, China;(2)Fuzhou University, College of Physics and Information Engineering, Fuzhou, China;(3)The Sixth Affiliated Hospital of Sun Yat-sen University, Department of Radiology, Guangzhou, China;
